跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 3 天前AI 评分22

Novo 重塑其直接面向消费者平台;罗氏药物Gazyva再次获批

Novo revamps its direct-to-consumer platform; Roche drug Gazyva approved again

AI 导读

罗氏药物Gazyva再次获批;Novo重新推出了其直接面向消费者的NovoCare平台。

正文

Plus news about Uniq­ui­ty Bio, Com­mit Bi­o­log­ics, Rose­mont Phar­ma­ceu­ti­cals, Ay­tu and Aclaris Ther­a­peu­tics.

No­vo re­launch­es Novo­Care di­rect-to-con­sumer plat­form: No­vo is re­vamp­ing its

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news